0314: Sipai Health Technology Co., Ltd. - Summary | Jitta

Sipai Health Technology Co., Ltd.

HKG:0314

Price
HK$1.18
Loss Chance
54.1%
2.92JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
1,430 / 2,517
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (45)
Recent Business Performance (44)
Financial Strength (24)
Return to Shareholders (4)
Competitive Advantage (32)
Jitta Signs
SG&A to SalesDecreasing
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2024
Operating MarginDeclined
Recent Business PerformanceEarning decline 84.62% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
2.92
100.00%
3.92
250.38%
Drug Retail
4.72
56.84%
5.20
> 1,000%
5.18
60.08%
COMPANY DESCRIPTION
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People’s Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment provides specialty pharmacies and value-added professional pharmacist services; focuses on innovative medicines for the treatment of oncology; pharmaceutical supply chain network for health insurance services; and other critical illnesses. The Physician Research Assistance Business segment offers pharmaceutical companies and other clinical trial institutions site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and others; and services for image management in clinical trials. The Health Insurance Services Business segment provides insurance brokerage services to insurance companies; and health management services to insurance carriers and enterprise clients. The company was founded in 2014 and is headquartered in Putuo, the People’s Republic of China.